AKT1 and neoplasm: Zheng et al. demonstrated that exosomal-carrying tumor-related macrophages, miRNA-21, confers cisplatin refractoriness in gastric cancer through upregulating the PI3K/Akt pathway via the inhibition of phosphatase and tensin homolog (PTEN) [43].